Targeted 19F MRI for molecular imaging of the immune response and its theranostics
Immunotherapy Advances · 31.12.2025 · 6 (1)
DOI: 10.1093/immadv/ltaf035 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunotherapy Advances, online erschienen am 01.12.2025. Verfasst von Pascal Bouvain und 2 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Cardiovascular Imaging, Molecular Cardiology, Heinrich Heine University, Düsseldorf 40225, Germany. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
The in vivo visualization of inflammatory processes offers not only the possibility of localizing disease but also of monitoring its progression over time. Among available imaging modalities, combined 1H/19F MRI has emerged as a powerful technique, as it enables the detection of inflammation with minimal background signal. Beyond diagnosis, however, there is increasing interest in using this platform to initiate targeted therapeutic interventions. The integration of these two components—diagnosis and therapy—is commonly referred to as theranostics. In this review, we provide an overview of the potential of fluorine-based MRI and highlight a range of targeted theranostic applications across different disease models. Particular emphasis is placed on recent strategies to manipulate neutrophils during acute colitis, which have demonstrated significant improvements in disease outcome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Experimental Cardiovascular Imaging, Molecular Cardiology, Heinrich Heine University, Düsseldorf 40225, Germany.
- Department of Anesthesiology, University Hospital Düsseldorf, Düsseldorf 40225, Germany.
- Cardiovascular Research Institute Düsseldorf (CARID), Heinrich Heine University, Düsseldorf, Germany.
ORCID-Profile: Pascal Bouvain, Sebastian Temme, Ulrich Flögel
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Bouvain, P., Temme, S., & Flögel, U. (2025). Targeted 19F MRI for molecular imaging of the immune response and its theranostics. Immunotherapy Advances, 6(1). https://doi.org/10.1093/immadv/ltaf035
Vancouver
Bouvain P, Temme S, Flögel U. Targeted 19F MRI for molecular imaging of the immune response and its theranostics. Immunotherapy Advances. 2025;6(1). doi:10.1093/immadv/ltaf035
BibTeX
@article{Bouvain2025,
author = {Bouvain, Pascal and Temme, Sebastian and Flögel, Ulrich},
title = {Targeted 19F MRI for molecular imaging of the immune response and its theranostics},
journal = {Immunotherapy Advances},
year = {2025},
volume = {6},
number = {1},
doi = {10.1093/immadv/ltaf035}
}
EUVIMED